Seizures following cardiopulmonary bypass

Journal of Extra-Corporeal Technology

Volumn 48, Issue 3, 2016, Pages 137-140

  Brouwer, Monique E ^a   McMeniman, William J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Cardiopulmonary bypass; Seizures; Tranexamic acid

Indexed keywords

CEFAZOLIN; LEVETIRACETAM; METARAMINOL; MIDAZOLAM; MILRINONE; NORADRENALIN; PHENYTOIN; PROPOFOL; TRANEXAMIC ACID; ANTICONVULSIVE AGENT;

AGED; AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTERIAL FILTER; ARTICLE; BRAIN PERFUSION; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS CANNULA; CASE REPORT; FIBRINOLYSIS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE OXYGENATOR; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; ROLLER PUMP; SEIZURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VENTRICULAR VENT; ADVERSE EFFECTS; DIFFERENTIAL DIAGNOSIS; SEIZURES;

AGED; ANTICONVULSANTS; CARDIOPULMONARY BYPASS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; SEIZURES; TREATMENT OUTCOME;

EID: 85006967973     PISSN: None     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996;335: 1857-63.
2. Goldstone AB, Bronster DJ, Anyanwu AC, et al. Predictors and outcomes of seizures after cardiac surgery: A multivariable analysis of 2, 578 patients. Ann Thorac Surg. 2011;91:514-9.
3. Sharma V, Katznelson R, Jerath A, et al. The association between tranexamic acid and convulsive seizures after cardiac surgery: A multivariate analysis in 11 529 patients. Anaesthesia. 2014;69:124-30.
4. Manji RA, Grocott HP, Leake J, et al. Seizures following cardiac surgery: The impact of tranexamic acid and other risk factors. Can J Anaesth. 2012;59:6-13.
5. Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg. 2012;93: 148-55.
6. Harrison MJG. Neurologic complications of coronary artery bypass grafting: Diffuse of focal ischemia? Ann Thorac Surg. 1995;59: 1356-8.
7. Hunter GRW, Young GB. Seizures after cardiac surgery. J Cardiothorac Vasc Anesth. 2011;25:299-305.
8. Muth CM, Shank ES. Gas Embolism. N Engl J Med. 2000;342: 476-82.
9. Hogue CW, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: An evidence-based appraisal of current practices. Anesth Analg. 2006;103:21-37.
10. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1998;55:1475-82.
11. Mitchell SJ, Willcox T, McDougal C, Gorman DF. Emboli generation by the Medtronic Maxima hard-shell adult venous reservoir in cardiopulmonary bypass circuits: A preliminary report. Perfusion. 1996;11:145-55.
12. Mitchell SJ, Willcox T, Gorman DF. Bubble generation and venous air filtration by hard-shell venous reservoirs: A comparative study. Perfusion. 1997;12:325-33.
13. Doganci S, Gunaydin S, Murat Kocak O, Yilmaz S, Demirkilic U. Impact of the intensity of microemboli on neurocognitive outcome following cardiopulmonary bypass. Perfusion. 2013;28:256-62.
14. Jabur GNS, Willcox TW, Zahidani SH, Sidhu K, Mitchell SJ. Reduced embolic load during clinical cardiopulmonary bypass using a 20 micron arterial filter. Perfusion. 2014;29:219-25.
15. Brooker RF, Brown WR, Moody DM, et al. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:1651-5.
16. Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995;110:1302-11; discussion 1311-14.
17. Charlson ME, Peterson JC, Krieger KH, et al. Improvement of outcomes after coronary artery bypass II: A randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg. 2007;22:465-72.
18. Engelman R, Baker RA, Likosky DS, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of Extracorporeal Technology: Clinical practice guidelines for cardiopulmonary bypass-temperature management during cardiopulmonary bypass. Ann Thorac Surg. 2015;100:748-57.
19. Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115:2801-13.
20. Murkin J, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg. 2010;110:350-3.
21. Koster A, Börgermann J, Zitterman A, Lueth JU, Gillis-Januszewski T, Schimer U. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: Incidence and clinical outcome. Br J Anaesth. 2012;110:34-40.
22. Tranexamic Acid [package insert]. Hospira Pty Ltd., Melbourne, VIC; 2015.
23. Lecker I, Wang D, Romaschin AD, Peterson M, Mazer CD, Orser BA. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest. 2012;122:4654-66.
24. Furtmuller R, Schlag MG, Berger M, et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gammaaminobutyric acid (A) receptor antagonistic effect. J Pharmacol Exp Ther. 2002;301:168-73.